ACE2 Mouse Models ā Humanized and Conditional/Knockout Mice
Mouse models play a critical role in both vaccine and drug development. Studies have shown that SARS-CoV-2 binds to the angiotensin-converting enzyme 2 (ACE2) receptor on the surface of human cells through the spike protein (S protein).
Many different hACE2 transgenic mouse models have been developed for in vivo experimental platform for COVID-19 research. We are prioritizing our support in COVID-19 research. Check out the list of ACE2 mouse models in the table below.
ACE2 Mouse Models
| ACE2 Mouse Models | Background Strain | Description |
| Humanized ACE2 (hACE2) Mice
(All Humanisation) Ā |
C57BL/6JGpt | Ā·Ā CRISPR/Cas9 Knockin (KI)
Ā·Ā Mouse ACE2 replaced by human ACE2 Ā·Ā Human ACE2 expressed under the control of mouse promoter |
| BALB/cJGpt | ||
| Humanized ACE2 (hACE2) Mice
(Extracellular Humanisation) |
C57BL/6JGpt | Ā·Ā CRISPR/Cas9 Knockin (KI)
Ā·Ā Mouse-derived ACE2 signal peptide inserted into the human-mouse chimeric CDS Ā·Ā Human-mouse chimeric ACE2 expressed under the control of mouse promoter |
| NCG-hACE2
Ā |
NOD/ShiLtJGpt | Ā·Ā CRISPR/Cas9 Knockin (KI)
Ā·Ā Triple-immunodeficient mice Ā·Ā Mouse ACE2 replaced by human ACE2 Ā·Ā Human ACE2 expressed under the control of mouse promoter Ā·Ā Can be immuno-humanized using PBMC or CD34+ cell engraftments |
| H11-K18-hACE2 | C57BL/6JGpt | Ā·Ā CRISPR/Cas9 Knockin (KI)
Ā·Ā Mouse model that over-expresses human ACE2 under K18 (human cytokeratin 18) promoter at the safe island H11 site |
| ACE2 Conditional Knockout Model | C57BL/6JGpt | Ā· Conditional knockout (cKO) CRISPR/Cas9
Ā· ACE2 knockout in specific tissues and cells after mating with mice expressing Cre recombinase |
| ACE2 Knockout Model | C57BL/6JGpt | Ā· CRISPR/Cas9 Knockout (KO)
Ā· ACE2 global knockout |
Ā
Selected Publications:
Ma X, Zou F, Yu F, et al., Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses. Immunity 2020 53(6):1315-1330. e9; doi.org/10.1016/j.immuni.2020.11.015 (IF: 31.745)
Qiao J, Li Y-S, Zeng R, et al., SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model. Science 2021;371(6536):1374-1378; DOI: 10.1126/science.abf1611 (IF 47.728)
Li T, Han X, Gu C, et al., Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants. Nature communications 2021;12(1):1-11; doi.org/10.1038/s41467-021-26539-7 (IF: 14.919)
Zhang S, Huang W, Ren L, et al., Comparison of viral RNAāhost protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2. Cell Research 2021:1-15 doi.org/10.1038/s41422-021-00581-y (IF:25.617)
Custom Animal Models for COVID-19 Research
We also offer custom animal models to meet the requirements for your COVID-19 study. If you need other COVID-19 models, send in your inquiries and we will assist you.
Documents
hACE2 Extracellular humanization strain info
H11-K18-hACE2 strain info
B6-HuACE2_FL strain info
NCG-hACE2(all humanization) strain info
BALB_c-hACE2(all humanization) strain info
